Showing results (1-10 of 99) with videos related to
Sort By:
Pageof 10
AIMS Microbiology|July 12, 2019
Autoimmune liver disease and the enteric microbiomeKerri Glassner, Eamonn Mm Quigley, Lissa Franco, et al.The American Journal of Gastroenterology|October 5, 2013
PARs for the course: roles of proteases and PAR receptors in subtly inflamed irritable bowel syndromeEamonn Mm QuigleyGenome Medicine|September 29, 2012
Epigenetics: filling in the 'heritability gap' and identifying gene-environment interactions in ulcerative colitisEamonn Mm QuigleyJournal of Clinical Gastroenterology|October 13, 2022
Irritable Bowel Syndrome Symptoms in Nonalcoholic Fatty Liver Disease Patients Are an Indicator of Depression and AnxietyLissa Franco, Michelle Jones-Pauley, Omar Tamimi, et al.Current Opinion in Pharmacology|February 11, 2018
Therapeutic implications of the gastrointestinal microbiomePurna C Kashyap, Eamonn Mm QuigleyExpert Review of Gastroenterology & Hepatology|February 13, 2009
Diagnosis of small intestinal bacterial overgrowth: the challenges persist!Ahmed Abu-Shanab, Eamonn Mm QuigleyInternational Journal of Immunopathology and Pharmacology|October 26, 2020
The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basisHüseyin S Bozkurt, Eamonn Mm QuigleySAGE Open Medicine|February 6, 2019
Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer preventionHüseyin Sancar Bozkurt, Eamonn Mm Quigley, Banu KaraAmerican Journal of Preventive Cardiology|July 30, 2021
Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular diseaseTanushree Agrawal, Isaac Acquah, Amit K Dey, et al.Current Opinion in Gastroenterology|March 18, 2021
Positioning biologics and small molecules in the management of moderate to severe ulcerative colitisBincy Abraham, Kerri GlassnerPageof 10